Results 181 to 190 of about 397,641 (218)

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Barriers and facilitators for the uptake of the national INOCA recommendation among Dutch cardiologists: A survey study. [PDF]

open access: yesInt J Cardiol Cardiovasc Risk Prev
Göttgens I   +4 more
europepmc   +1 more source

Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali   +4 more
wiley   +1 more source

FoldaVirus, a knowledge-based icosahedral capsid prediction tool using AlphaFold. [PDF]

open access: yesProc Natl Acad Sci U S A
Rojas Labra O   +6 more
europepmc   +1 more source

Developing a Dashboard to Stimulate Independent Functioning in Older Persons in District Nursing Care. [PDF]

open access: yesComput Inform Nurs
van den Braak KPM   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy